Source: Health Canada shortage reports · Updated Jul 10, 2026
Some Duloxetine products are in shortage in Canada (4 of 32 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 10, 2026.
An antidepressant (SNRI) used to treat depression, anxiety and certain types of nerve pain.
Products affected
4 / 32
In shortage since
Nov 4, 2025
Est. full return
Oct 10, 2026
Reports on file
127
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-DULOXETINE
60MG · CAPSULE (DELAYED RELEASE) · APOTEX INC
DIN 02440431 · since Nov 4, 2025, est. end Jul 3, 2026 · Disruption of the manufacture of the drug.
DIN 02439956 · ended Sep 15, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Duloxetine is currently affected by 4 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Duloxetine is classified under “ANTIDEPRESSANTS” (ATC N06AX).
Recent changes
Jul 10, 2026
Shortage resolved
Common questions
What is Duloxetine used for?
An antidepressant (SNRI) used to treat depression, anxiety and certain types of nerve pain.
When will Duloxetine be back in stock in Canada?
The latest manufacturer estimate is Oct 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Duloxetine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.